Overview A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects Status: Terminated Trial end date: 2013-05-01 Target enrollment: Participant gender: Summary The purpose of this study is to compare the safety and effect of HPP404 versus placebo on body weight in overweight or obese subjects. Phase: Phase 2 Details Lead Sponsor: High Point Pharmaceuticals, LLC.